Elderberry for Flu • African Herb F~.R B,Ronchitis • Tamanu Oil • Herb Qual~Ty

Total Page:16

File Type:pdf, Size:1020Kb

Elderberry for Flu • African Herb F~.R B,Ronchitis • Tamanu Oil • Herb Qual~Ty Elderberry for Flu • African Herb f~. r B,ronchitis • Tamanu Oil • Herb Qual~ty ' Number63 USA $6.95 CAN $7.95 7 25274 81379 7 If you think all bilberry extracts are alike, there's something you should know. There are almost 450 species of bilberry. But the only extract with clinically proven efficacy, lndena's Mirtoselect®, has always been made There are from a single species: Vaccinium myrtillus L. bilberries and To prove it, we can supply you with the unmistakable HPLC bilberries. fingerprint of its anthocyanin pattern. It may be tempting to save money using cheap imitations - but it's a slip-up your customers would prefer you avoid. To know more, call lndena today. I dlindena science is our nature™ www.indena.com [email protected] Headquarters: lndena S.p.A.- Viale Ortles, 12-20139 Milan -Italy- tel. +39.02.574961 lndena USA, Inc. - 811 First Avenue, Suite 218- Seattle, WA 98104 - USA- tel. + 1.206.340.6140 Yes, I want Membership Levels & Benefits to join the American Pkase add $20 for addmsli oursitk the U.S. Botanical Council! Individual - $50 Professional - $150 Please detach application and mail to: ~ Subscription to our highly­ All Academic membership American Botanical Council , P.O. Box 144345, acclaimed journal benefits, plus: Austin, TX 787 14-4345 or join online at www.herbalgram.org Herbal Gram ~5 0 % discount on first order 0 Individual - $50 ~ Access to members-only of single copies of ABC 0 Academic- $100 information on our website, publications from our Herbal 0 Professional - $150 www.herbalgram.org Education Catalog 0 Organization - $250 (Add $20 postage for imernarional delivery for above levels.) • HerbalGram archives ~ Black Cohosh Educational 0 Corporate and Sponsor levels • Complete German Module including free CE and (Comact Wayne Silverman, PhD, 512/926-4900, ext. 120.) CME credit Commission E NEW* Payment instructions Monographs ~ Popular Herbs in the U.S. 0 Charge credit card (Visa or MC only) • Herbal Medicine: Expanded Market Therapeutic # -------------- Commission E Monographs Monographs, a sixty-eight page exp. date: ____________ • Botanical Booklet Series book on 26 herbs NEW* • Herb Reference Guide ~ Membership certificate (Please include the 3-digit number following the • Common Herbs Described Organization - $250 account# on signature line on back of card. ) ~ News and information from For nonprofit organizations and ABC's e-mail newsletter NEW* libraries. 0 Send invoice ro the address below ~ Free 112 hour research session All Professional membership 0 Check enclosed with our education department benefits, plus: 0 Do not share my conracr info ~ 40% discount on additional ~ 2 subscriptions to our highly­ 0 Do not include me ro receive e-mail research from our education acclaimed journal HerbalGram newsletter department ~Access for up to 3 user logins from your facility to the ~ 10% discount on publications name from our Herbal Education members-only sections on our Catalog website, www.herbalgram.org company ~ Membership card Corporate and Sponsor Membership Academic- $100 profession/title Small to large organizations can All Individual membership receive additional benefits, includ­ benefits, plus: phone ing the bi-weekly HerbClip mailing -. Onliue access to: service, and also extend their fax • HerbClipTM Online, 2300 support to ABC's mission through critical reviews Corporate or Sponsor level address • HerbMedPro TM evidence­ membership. To learn more, please based herbal studies from contact Wayne Silverman, PhD, at the Alternative Medicine wsi [email protected], or Foundation 800-373-7105 x120. ciry state/province ~ Garlic chapter reprint from The ABC Clinical Guide to zi p/ postal code Herbs NEW* country hv1ERICflN e-mail * New benefit, not previously offered. BoTfNICAL COUNCIL HG63 advisory board Each iss ueo f Herba!Gram isp eer reviewed by membersof our Ad visory Board and other qua lified experts before publication. Cindy K. Angerhofer, Ph.D. Hardy Eshbaugh, Ph.D Joseph E. Pizzomo, Jr., N.D. Director of Botanical Research, Aveda Institute, Professor of Botany &Assistant Cu rator, Willard Sherman Turrell President Emeritus, Bastyr University, Seattle, Washington, and Minneapolis, Minnesota Herbarium, Miami University, Oxfo rd, Ohio Editor, Integrative Medicine: AClinician~ Journal John Thor Amason, Ph.D. Adriane Fugh-Berman, M.D. Mark J. Plotkin, Ph.D. Professor of Biology, Department of Biology, Author, Assistant Clinical Professor, George Washington University Au thor, Executive Director, Amazon Conservation Team, University of Ottawa, Ontario, Canada School of Medicine, Washington, DC Arlington, Virginia Dennis V. C. Awang , Ph.D., F.C.I.C. Joe Graedon, M.S. John M. Riddle, Ph.D. MediPiant Natural Products Consulting Services, Auth or, synd icated columnist, radio host, Du rham, North Carolina Professor of Hi story, Departmen t of History, White Rock, B.C., Canada North Caro lina State University, Raleigh Mary Hardy, M.D. Manuel F. Balandrin, R.Ph., Ph.D. Director, Ceda rs-Sinai IntegrativeMe dicine Medical Group, Eloy Rodriguez, Ph.D. Research Scientist, NPS Pharmaceuticals, Salt Lake City, Utah Los Angeles, Californ ia James Perkins Professor of Env ironmental Studies, School of Agriculture& Life Sciences, Cornell University, Ithaca, New York Bruce Barrett, M.D., Ph.D. Christopher Hobbs, LAc., AHG Assistant Professor of Family Medicine, University of Herbalist, botanist, licensed acupuncturist, Davis, California Victor Sierpina, M.D. Wisconsin-Madison Medical School Associate Professor of Family Practice Medicine, David Hoffmann, B.Sc., M.N.I.M.H University ofTexas Medical Branch, Galveston Marilyn Barrett, Ph .D. Medical herbalist, author, Santa Rosa, California Pharmacognosy Consulting Service, San Carlos, California James E. Simon, Ph.D. Maurice M.lwu, Ph.D. Professor of New Use Agriculture, Director of theCe nter for New Use Bradley C. Bennett, Ph.D. Bioresources Development and Conservation Program, Senior Agriculturean d Natural Plant Products, Rutgers University, Associate Professor of Biology, Florida International University, Research Associateat theD ivision of Experimental Therapeutics, New Brunswick, New Jersey Miami Wa lter Reed Army Institute of Research, Washington, D.C. Beryl Simpson, Ph.D. Joseph M. Betz, Ph.D. TimothyJohns , Ph .D. C. L. Lundell Professor of Botany, Department of Botany, Director of the Dietary Supplements Methods and Reference Professor, School of Dietetics and Human Nutrition; Centre for University ofTexas at Austin Materials Program, Office of Dietary Supplements, National Indigenous People's Nutrition and the Environment, McGill Institutes of Health, Bethesda, Maryland University, Montreal, Canada S. H. Sohmer, Ph .D. President and Director, Botanical Research InstituteofTexas, Francis Brinker, N.D. Steven King, Ph.D. Fort Worth Clinical Assistant Professor, Department of Medicines, Vice President, PS Pharmaceuticals, Inc., Program in Integrative Medicine, University of Arizona, Tucson Sou th San Francisco, California Barbara N. Timmermann, Ph.D. Professor of Pharmacology and Toxicology, College of Pharmacy, Donald J. Brown, N.D. Tieraona low Dog, M.D. University of Arizona, Tucson Director, Natural Products Research Consultants, Seattle, Washington Cl inical Asst Professor, Director of Botanical Studies, Program in Integrative Medicine, University of Arizona School of Medicine, G. H. Neil Towers, Ph .D. Thomas J.S. Carlson, M.S., M.D. Tucson, Arizona Professor Emeritus, F. R. S.C., Botany Department, Associate Adjunct Professor, University of British Co lumbia, Va nco uve r, Canada Department of Integrative Biology; Director, Center for Health, Tom Mabry, Ph .D. Ecology, Biodiversity, & Ethnobiology; Curator of Ethnobotany, Professor of Plant Biochemistry, Department of Botany, Arthur 0. Tucker, Ph.D. University and Jepson Herbaria; University of California, Berkeley Universi ty ofTexas at Austin Research Professor of Agricultureand Natural Resources, Delaware State University, Dover Jean Carper Gail B. Mahady, Ph .D. Author and syndicated columnist, Washington, D.C. Resea rch Assistant Professor, Department of Medical Chemistry & Nancy Turner, Ph .D. Pharmacognosy, College of Pharmacy, University of Illinois, Chicago Professor and Ethnobotanist, Environmental Studies Program, Jerry Cott, Ph.D. University of Victoria, British Columbia, Canada Pharmacologist, U.S. Food and Drug Administration, Robin J. Maries, Ph.D. Center for Drug Evaluation and Research, Rockville, Maryland Director of the Bureau of Research and Science, Natural Health Daniel T. Wagner, R.Ph., MBA, Pharm .D. Products Directorate, Health Productsa nd Food Branch, Owner, Nutri-Farmacy, Wildwood, Pennsylvania Paul Alan Cox, Ph.D. Health Canada, Ottawa Director, National Tropical Botanical Garden, Kauai, Hawaii Andrew T. Weil, M.D. Dennis J. McKenna, Ph.D. Author, Director of the Program in Integrative Medicine and lyle E. Craker, Ph.D. Executive Director, Institute for Natural Products Resea rch; Associate Director of the Division of Social Perspectives in Medicine, Professor, Department of Plant and Soil Sciences, Senior Lecturer, Center for Spirituality and Healing, University of College of Medicine, University of Arizona, Tucson University of Massachusetts, Amherst Minnesota, Minneapolis Bernd Wollschlaeger, M.D. Edward M. Croom, Jr., Ph .D. Daniel E. Moerman, Ph.D. Family practice physician; Clinical Assistant Professor of Medicine Scientific and Regulatory Affairs Manager, lndena USA East, Inc., William E. Stirton Professor of Anthropology, an d Family
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2011/0039031 A1 Cobham Et Al
    US 2011 0039031A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0039031 A1 Cobham et al. (43) Pub. Date: Feb. 17, 2011 (54) CARRIER, FORMULATION AND METHOD Publication Classification FOR THE TREATMENT OF TIMBER (51) Int. Cl. (75) Inventors: Peter Cobham, Queensland (AU); C09D 5/14 (2006.01) David Humphrey, Victoria (AU); BSD L/02 (2006.01) BOSD I/28 (2006.01) Brett Skewes, Victoria (AU) BSD L/18 (2006.01) Correspondence Address: (52) U.S. Cl. ........ 427/427.7: 106/18: 106/311; 427/440; BELL & ASSOCATES 427/428.01 58 West Portal Avenue No. 121 SAN FRANCISCO, CA 94127 (US) (57) ABSTRACT (73) Assignee: Arch Wood Protection Pty Ltd According to the present invention there is provided a carrier Appl. No.: composition for migration and/or redistribution of a preser (21) 12/989,417 vative formulation within wood or engineered wood prod (22) PCT Fled: Apr. 24, 2009 ucts, said carrier system comprising a drying oil and/or a semi-drying oil and an extender. There is also provided a (86) PCT NO.: PCT/AU09/00525 preservative formulation comprising Such a carrier composi tion and a method of treating wood comprising the step of S371 (c)(1), applying Such a preservative formulation to the wood or engi (2), (4) Date: Oct. 24, 2010 neered wood product. Patent Application Publication Feb. 17, 2011 Sheet 1 of 3 US 2011/0039031 A1 F.G. 3 F.G. 4 Patent Application Publication Feb. 17, 2011 Sheet 2 of 3 US 2011/0039031 A1 F.G. S F.G.
    [Show full text]
  • Quantitative Analysis of Phosphatidylethanolamine and Phosphatidylcholine from Rice Oil Lecithin and Sunflower Oil Lecithin by A
    Applikationsbericht Quantitative Analysis of Phosphatidylethanolamine and Phosphatidylcholine from Rice Oil Lecithin and Sunflower Oil Lecithin by ACQUITY UPLC H-Class Plus System with PDA Detection Dilshad Pullancheri, Dr. Gurubasavaraj HM, Bheeshmacharyulu. S, Dr. Padmakar Wagh, Shaju V A, Ramesh Chandran K, Rajeesh K R, Abhilash Puthiyedath Waters Corporation, Kancor Ingredients Ltd. Abstract In this application note, we have developed a 15 minutes method for quantitative analysis of PE and PC on the ACQUITY UPLC H-Class Plus System with a PDA Detector. Benefits Quantification of PE and PC in rice and sunflower oil lecithin within 15 minutes run time on the ACQUITY UPLC H-Class Plus System with a PDA Detector. Introduction Phospholipids are major constituents of cell membrane and are found in all tissues and subcellular compartments as mixtures of various molecular species such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), sphingomyelin (SM), and lysophosphatidylcholine (LPC) depending on the type of polar head groups and the degree of unsaturation of the acyl chains. Among these phospholipids, PC and PE represents a major constituent of cell membranes. The demand for lecithin with high PC and PE content from vegetable or cereal source is increasing these days, particularly in pharmaceutical, cosmetic, food, and other applications due to their emulsifying properties and nonantigenic nature. The application of lecithins in pharmaceutical and cosmetics domain depends mainly on the PC and PE with its saturated or unsaturated fatty acid content. Figure 1. Classification of phospholipids. The present method of UltraPerformance Liquid Chromatography (UPLC) with UV detection offers advantages of high speed, resolution and simplicity for the separation and detection of phospholipids including phosphatidylcholine and phosphatidylethanolamine from rice and sunflower oil lecithin.
    [Show full text]
  • The Promotion of False Or Misleading Health-Related Information Or Practices
    Submission No 23 THE PROMOTION OF FALSE OR MISLEADING HEALTH-RELATED INFORMATION OR PRACTICES Organisation: School of Law, Faculty of Business, Government & Law University of Canberra Name: Asst Professor Bruce Arnold Position: Assistant Professor Date Received: 2/02/2014 Committee on the Health Care Complaints Commission Parliament House Macquarie St Sydney NSW 2000 INQUIRY INTO THE PROMOTION OF FALSE OR MISLEADING HEALTH- RELATED INFORMATION OR PRACTICES This submission responds to the Committee’s call for public comment on the promotion of false or misleading health-related information or practices. In summary, false/misleading information and practices has the potential to • directly affect consumers of that information/practice and • indirectly result in serious injury to people (particularly children) who are exposed to infections attributable to misleading information disseminated by ‘anti-vaccination’ advocates or who are dissuaded from engaging with science-based medicine. it is desirable for the New South Wales Government, through the Council of Australian Governments and health-sector policy and standard-setting bodies, to foster a coherent national regime that deals with the promotion of false or misleading health-related information or practices. Such a regime involves consistency across jurisdictions, public education, action by regulators such as the Australian Competition & Consumer Commission and Health Care Complaints Commission, and greater engagement by boards under the Australian Health Practitioner Regulation Agency with practitioners who promote false or misleading health-related information and practices. Strengthening the powers of the Health Care Complaints Commission through the Health Legislation Amendment Act 2013 (NSW) was appropriate. Protection of consumers in the state should be enhanced through resourcing of the Commission that ensures it is able to give effect to the legislation.
    [Show full text]
  • Nebulised Antibiotherapy: Conventional Versus Nanotechnology- Based Approaches, Is Targeting at a Nano Scale a Difficult Subject?
    448 Review Article Page 1 of 16 Nebulised antibiotherapy: conventional versus nanotechnology- based approaches, is targeting at a nano scale a difficult subject? Esther de Pablo1, Raquel Fernández-García1, María Paloma Ballesteros1,2, Juan José Torrado1,2, Dolores R. Serrano1,2 1Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/ n, Madrid, Spain; 2Instituto Universitario de Farmacia Industrial (IUFI), Facultad de Farmacia, Universidad Complutense de Madrid, Avenida Complutense, Madrid, Spain Contributions: (I) Conception and design: E de Pablo; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: None; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Dolores R. Serrano. Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, Madrid 28040, Spain. Email: [email protected]. Abstract: Nebulised antibiotics offer great advantages over intravenously administered antibiotics and other conventional antibiotic formulations. However, their use is not widely standardized in the current clinical practice. This is the consequence of large variability in the performance of nebulisers, patient compliance and a deficiency of robust preclinical and clinical data. Nebulised antibiotherapy may play a significant role in future pulmonary drug delivery treatments as it offers the potential to achieve both a high local drug concentration and a lower systemic toxicity. In this review, the physicochemical parameters required for optimal deposition to the lung in addition to the main characteristics of currently available formulations and nebuliser types are discussed.
    [Show full text]
  • Effects of Phosphatidylethanolamine and Phosphatidylcholine in Membrane Phospholipid on Binding of Phorbol Ester in Rat Mammary Carcinoma Cells1
    [CANCER RESEARCH 48, 1528-1532, March 15, 1988J Effects of Phosphatidylethanolamine and Phosphatidylcholine in Membrane Phospholipid on Binding of Phorbol Ester in Rat Mammary Carcinoma Cells1 Tamiko Kano-Sueoka2 and David M. King Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado S0309 ABSTRACT sphingomyelin are however not altered (5, 6). Etn-responsive cells are not able to synthesize, without an exogenous supply Mammalian cells in culture can be classified as either ethanolamine of Etn, a sufficient amount of PE to maintain growth (6). (Etn)-responsive or Etn-nonresponsive with regard to their growth. Epi Growth and phospholipid compositions of fibroblasts, neuro- thelial cells and some of their transformed derivatives are the Etn- cells, and certain neoplastic cells of epithelial origin, on the responsive type. When these cells are grown without Etn, the content of other hand, are not influenced by Etn in culture medium (2, 5). membrane phospholipid becomes significantly altered. Namely, the con tent of phosphatidylethanolamine is reduced and that of phosphatidyl- When Etn-responsive cells are grown without Etn, as the choline is increased. In addition, the growth rate of these cells is reduced. content of membrane PE is reduced, the growth slows down. Therefore, it is likely that the phosphatidylethanolamine deficiency or The reason as to why PE deficiency leads to the cessation of phosphatidylcholine excess is unsuitable for some membrane-associated cell proliferation could be that the PE synthesis is somehow functions resulting in the cessation of growth. In order to test the above tied to cell growth or the PE deficiency creates unfavorable hypothesis, we examined the binding of a tumor-promoting phorbol ester, conditions for the membrane-associated function, resulting in |'H|phorbol 12,13-dibutyrate (PDB), to an Etn-responsive rat mammary the cessation of growth.
    [Show full text]
  • Nicotine and Methylphenidate Chornic Exposure on Adult Cannabinoid Receptor Agonist (Cp 55,940) Place Conditioning in Male Rats
    California State University, San Bernardino CSUSB ScholarWorks Electronic Theses, Projects, and Dissertations Office of aduateGr Studies 6-2016 NICOTINE AND METHYLPHENIDATE CHORNIC EXPOSURE ON ADULT CANNABINOID RECEPTOR AGONIST (CP 55,940) PLACE CONDITIONING IN MALE RATS Christopher P. Plant California State University - San Bernardino Follow this and additional works at: https://scholarworks.lib.csusb.edu/etd Part of the Biological Psychology Commons, and the Clinical Psychology Commons Recommended Citation Plant, Christopher P., "NICOTINE AND METHYLPHENIDATE CHORNIC EXPOSURE ON ADULT CANNABINOID RECEPTOR AGONIST (CP 55,940) PLACE CONDITIONING IN MALE RATS" (2016). Electronic Theses, Projects, and Dissertations. 339. https://scholarworks.lib.csusb.edu/etd/339 This Thesis is brought to you for free and open access by the Office of aduateGr Studies at CSUSB ScholarWorks. It has been accepted for inclusion in Electronic Theses, Projects, and Dissertations by an authorized administrator of CSUSB ScholarWorks. For more information, please contact [email protected]. NICOTINE AND METHYLPHENIDATE CHRONIC EXPOSURE ON ADULT CANNABINOID RECEPTOR AGONIST (CP 55,940) PLACE CONDITIONING IN MALE RATS A Thesis Presented to the Faculty of California State University, San Bernardino In Partial Fulfillment of the Requirements for the Degree Master of Arts in General-Experimental Psychology by Christopher Philip Plant June 2016 NICOTINE AND METHYLPHENIDATE CHRONIC EXPOSURE ON ADULT CANNABINOID RECEPTOR AGONIST (CP 55,940) PLACE CONDITIONING IN MALE
    [Show full text]
  • 1 Recurrent Loss of Abaa, a Master Regulator of Asexual Development in Filamentous Fungi
    bioRxiv preprint doi: https://doi.org/10.1101/829465; this version posted November 4, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Recurrent loss of abaA, a master regulator of asexual development in filamentous fungi, 2 correlates with changes in genomic and morphological traits 3 4 Matthew E. Meada,*, Alexander T. Borowskya,b,*, Bastian Joehnkc, Jacob L. Steenwyka, Xing- 5 Xing Shena, Anita Silc, and Antonis Rokasa,# 6 7 aDepartment of Biological Sciences, Vanderbilt University, Nashville, Tennessee, USA 8 bCurrent Address: Department of Botany and Plant Sciences, University of California Riverside, 9 Riverside, California, USA 10 cDepartment of Microbiology and Immunology, University of California San Francisco, San 11 Francisco, California, USA 12 13 Short Title: Recurrent loss of abaA across Eurotiomycetes 14 #Address correspondence to Antonis Rokas, [email protected] 15 16 *These authors contributed equally to this work 17 18 19 Keywords: Fungal asexual development, abaA, evolution, developmental evolution, 20 morphology, binding site, Histoplasma capsulatum, regulatory rewiring, gene regulatory 21 network, evo-devo 22 1 bioRxiv preprint doi: https://doi.org/10.1101/829465; this version posted November 4, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 23 Abstract 24 Gene regulatory networks (GRNs) drive developmental and cellular differentiation, and variation 25 in their architectures gives rise to morphological diversity.
    [Show full text]
  • Panacea-BOCAF On-Line University
    Panacea‐BOCAF On‐Line University The Panacea University presents OPEN SOURCE material and minimum donation resources which help us educate the world. This online university is not officially “recognized” or a “registered” faculty. The reason Panacea calls this online resource a university is simply because we present educational material. Welcome to the educational series covering alternative medicine towards building our children a future. Panacea‐BOCAF operates an educational non‐profit entity and is dedicated to educational study and research. All copyrights belong to their respective owners and are acknowledged. All material presented on this web site is either news reporting or information presented for non‐profit study and research. All info has previously been publicly disclosed or been implicitly put into the public domain. NOTE‐ Fair Use applies in this presentation. Contact us. Panacea‐BOCAF ‐Home Page Panacea University This document is COPYRIGHTED to Panacea. Panacea authorizes “helpers” to post this document on other file hosting sites, for example: Scribd, websites, blogs or any file sharing sites under the condition that it is kept in its original form, updated and credited to Panacea as being the sole author. Under no circumstances can this document be altered or sold without the express permission in writing by Panacea. We will enforce any abuse of this. If you are to post this document (and not the link), please note that Panacea updates this document frequently and only ask that you keep your uploaded copy up to date. Black Salve Alternative Cancer Treatment Centre Force ‐Herbal Black salve formula Disclaimer –Warning: This document contains graphic medical photos which may not be suitable to minors or the faint hearted etc.
    [Show full text]
  • Black Salve & Wings Heartdrops
    Black Salve & Wings Heartdrops Cleansing Time Pro Cleansing Time Pro Testimonials CANCER, VIRUS & HEART DISEASE PRODUCTS View Catalog NATURAL - EASY TO USE About Us USE IN THE COMFORT OF YOUR OWN HOME NO HEALTH INSURANCE REQUIRED Feel Good Tips Contact Us We have many testimonials to support our products from people who have used them to avoid major operations, radiation, chemotherapy & other drugs! We invite you FAQ's to read this entire page & click on the buttons to the left to learn more about these wonderful products. History Privacy Policy Cleansing TimeTM Pro Black Salve & Tablets: Useful Links All natural herbal cancer & virus treatment & preventative that is View Cart / the Checkout " ORIGINAL FORMULA" and is the Grandfather of black salve used for over 116 years! This product has been used successfully on humans , pets & animals to prevent cancer, treat & overcome a wide range of internal & external cancers, viruses and other illnesses. It starts working in 5 seconds! Known Uses for Cleansing TimeTM Pro Black Salve & Tablets ● Used in place of radiation therapy treatments & chemotherapy treatments ● Used to attack all known forms of cancer in & on the human & animal ● Used to eliminate fluid build up around tumors & shink them ● Used to normalize a-typical cells with the capability of becoming a cancer ● Used internally to treat & overcome a variety of cancers, malignancies & tumors. Used for stomach cancer, colon cancer, prostate cancer, testicular cancer, bladder cancer, throat cancer, thyroid cancer, mouth cancer, cervical
    [Show full text]
  • Black Salve in a Nutshell
    CLINICAL Black salve in a nutshell Andrew Croaker, Alvin Lim, BLACK SALVE is an alternative topical and bloodroot,8 and it was reportedly Cliff Rosendahl therapy used to treat skin cancer. It is developed after observing horses produced in a variety of formulations; cure themselves of cancerous lesions most formulations contain two core by grazing on certain plants. Hoxsey Background ingredients: bloodroot (Sanguinaria opened 17 clinics across the US, treating Black salve is an alternative therapy canadensis) and zinc chloride.1 Black salve several thousand patients in a multi- increasingly chosen by patients to self- 9 manage their skin lesions. It is promoted causes skin tissue destruction, resulting million dollar enterprise. The American as an effective, safe and natural skin in the formation of an eschar of necrotic Medical Association branded Hoxsey cancer treatment, but such claims are tissue that eventually sloughs away. a charlatan, and the US Food and Drug not evidence-based, and serious Bloodroot, a North American member Administration (FDA) mounted warnings complications have been reported. The of the poppy family, has rhizomes about Hoxsey’s formulas in 46,000 US sale of black salve in Australia is illegal. containing a red sap rich in cytotoxic post offices.10 2 Objective alkaloids, sanguinarine being the Dr Frederick Mohs noted in the 1930s The aim of this article is to educate alkaloid with the highest concentration. that zinc chloride fixed and histologically general practitioners (GPs) about black Zinc chloride, a synthetic corrosive preserved skin in vivo. Mohs developed salve, enabling informed discussion with chemical, is usually the main black salve a paste that used stibnite and bloodroot patients considering using black salve.
    [Show full text]
  • Performance and Emission Characteristics of Biodiesel Using with Tamanu Oil in Single Cylinder Four Stroke Diesel Engine
    IOSR Journal of Mechanical and Civil Engineering (IOSR-JMCE) e-ISSN: 2278-1684, p-ISSN: 2320-334X PP 55-60 www.iosrjournals.org Performance and Emission Characteristics of Biodiesel using with Tamanu Oil in Single Cylinder Four Stroke Diesel Engine Murugan K, Udhayakumar K Internal Combustion Engg, Department of Mechanical Engineering, University College of Engineering Villupuram , Villupuram 605103, India [email protected], [email protected] ABSTRACT: Tamanu oil (calophyllum inophyllum oil), a non-edible vegetable oil is native for northward of northenmarians islands and the ryukyu island in sarthen japan and westward throughout Polynesia. It has remained as an untapped new possible source of alternative fuel that can used in diesel engine. The present work examined the use of a Tamanu oil, a new possible source of alternative fuel for direct injection diesel engine. The blend of 20% Tamanu oil with 80% diesel can be used in unmodified diesel engine. The Brake thermal efficiency increases the engine. The emission like CO and HC and NOx emission reduced. Key words: Tamanu oli, Performance, Emission. I. INTRODUCTION: Our economy and lifestyle rely on the use of fossil resources for the transportation fuels and materials; however there has been rising concern over their cost, sustained availability, and impact on global warming and pollution [1]. This has led to a search for technologies that generate fuels and materials from renewable carbon sources, such as plant biomass. Depending on the component of the biomass used as feedstock and the technology employed to transform component into desired product, at least three general platforms have been envisioned: the sugar [2], synthesis gas [3], and oil [4] platforms.
    [Show full text]
  • The Relationship Between Arachidonic Acid Release and Catecholamine Secretion from Cultured Bovine Adrenal Chromaffin Cells
    Journal of Neurochemistry Raven Press, New York 0 1984 International Society for Neurochemistry The Relationship Between Arachidonic Acid Release and Catecholamine Secretion from Cultured Bovine Adrenal Chromaffin Cells Roy A. Frye and Ronald W. Holz Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan, U.S.A. ~ ~ Abstract: Increased arachidonic acid release occurred amine secretion, also stimulated arachidonic acid release. during activation of catecholamine secretion from cul- Because arachidonic acid release from cells probably re- tured bovine adrenal medullary chromaffin cells. The sults from phospholipase A, activity, our findings indicate nicotinic agonist l,l-dimethyl-4-phenylpiperazinium that phospholipase A, may be activated in chromaffin (DMPP) caused an increased release of preincubated cells during secretion. Key Words: Arachidonic acid- [3H]arachidonic acid over a time course which corre- Catecholamine secretion-Chromaffin cells-Phospho- sponded to the stimulation of catecholamine secretion. lipase A,. Frye R. A. and Holz R. W. The relationship Like catecholamine secretion, the DMPP-induced between arachidonic acid release and catecholamine se- [3H]arachidonic acid release was calcium-dependent and cretion from cultured bovine adrenal chromaffin cells. J. was blocked by the nicotinic antagonist mecamylamine. Neirrochem. 43, 146-150 (1984). Depolarization by elevated K+, which induced catechol- Prepackaged hormones and neurotransmitters In the present study we have investigated whether are usually released from cells via exocytosis. phospholipase A, activation (measured by release During exocytosis a rise in cytosolic [Ca2+]triggers of preincorporated [3H]arachidonic acid) occurs fusion of the secretory vesicle membrane and the during the stimulation of catecholamine secretion plasma membrane. Phospholipase A,, which may from cultured bovine adrenal medullary chromaffin be activated by a rise in cytosolic [Ca2+](Van den cells.
    [Show full text]